AR and metabolic syndrome: It has been reported that andropause, or late-onset hypogonadism, may induce obesity and metabolic syndrome, and testosterone replacement may potentially be an effective treatment for weight management in obese men with hypogonadism possibly mediated via the androgen receptor (AR) [7,8,9].